JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
ZoomInfo Technologies (ZI) IPO Opens 90% Higher
-
UPDATE: ZoomInfo Technologies Inc. (ZI) Prices 44.5M Class A Share IPO at $21/Sh
-
ZoomInfo Announces Pricing of its Initial Public Offering
-
Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
-
Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
-
Incyte to Present at Upcoming Investor Conferences
-
Vroom Announces Launch of Initial Public Offering
-
BioCryst Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
-
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
-
argenx announces closing of global offering
-
argenx announces closing of global offering
-
Baudax Bio Secures $50 Million Credit Facility
-
Baudax Bio Secures $50 Million Credit Facility
-
Hurricanes may cause more pain for pandemic-hit insurers
-
Allogene (ALLO) PT Raised to $53 at JMP Securities
-
TPG RE Finance Trust (TRTX) PT Raised to $10 at JMP Securities
-
Demandbase Extends Leadership Team To Drive Product Vision
-
Fiverr International (FVRR) Prices 2M Share Follow-On Offering at $60/Sh
-
argenx announces full exercise of underwriters’ option to purchase additional ADSs
-
argenx announces full exercise of underwriters’ option to purchase additional ADSs
-
Fiverr Announces Pricing of Follow-On Offering
-
Arena Pharma (ARNA) Prices 5.5M Share Common Offering at $50/Sh
-
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
argenx (ARGX) Prices 2.584M ADS Offering at $205/ADS; Announces Pricing of 1.07M Ordinary Share Offering at EUR186.52/Sh
-
BioCryst Pharma (BCRX) Prices 18.7M Share Common Offering at $4.50/Sh; Announces Pricing of Pre-Funded Warrants Offering
-
argenx raises $750 million in gross proceeds in a global offering
-
argenx raises $750 million in gross proceeds in a global offering
-
BioCryst Prices Public Offering of Common Stock and Pre-Funded Warrants
-
Blueprint Medicines to Present at Upcoming Investors Conferences
-
Arena Pharma (ARNA) Announces $250M Proposed Public Offering of Common Stock
-
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Trifacta Surpasses 100,000 Users and Six Million Jobs on its Data Preparation Platform and Bolsters Leadership Team with Cloud Expertise to Meet Market Demand
-
ZoomInfo Announces Launch of Its Initial Public Offering
-
Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
JMP Securities Starts Trillium Therapeutics (TRIL) at Market Outperform
-
JMP Securities Starts NextCure Inc. (NXTC) at Market Outperform
-
JMP Securities Resumes Compugen (CGEN) at Market Outperform
-
JMP Securities Starts Seattle Genetics (SGEN) at Market Outperform
-
Varonis Systems (VRNS) PT Raised to $90 at JMP Securities
-
Fiverr International Ltd. (FVRR) PT Raised to $67 at JMP Securities
-
JMP Securities Upgrades Cree (CREE) to Market Outperform
-
JMP Securities Downgrades Capitala Finance (CPTA) to Market Perform
-
Poxel Successfully Raises €17.7 Million in a Capital Increase
-
Gamida Cell Ltd. (GMDA) PT Lowered to $17 at JMP Securities, Following Earnings
-
Couchbase Announces $105 Million Equity Investment Led by GPI Capital to Fuel Its Next Phase of Growth and Cloud Innovation
-
Couchbase Announces $105 Million Equity Investment Led by GPI Capital to Fuel Its Next Phase of Growth and Cloud Innovation
-
Ocular Therapeutix (OCUL) Prices 8.2M Share Offering of Common Stock at $5.50/sh
-
Ocular Therapeutix™ Announces Pricing of Public Offering of Common Stock
-
RealPage (RP) Prices 5.085M Share Common Offering at $59/Sh; Announces Pricing of $300M Convertible Senior Notes Due 2025
-
RealPage Prices Offerings of Common Stock and Convertible Senior Notes


